Cytopenia, refractory w multilineage dysplasia
A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines. A minority of cases progress to acute myeloid leukemia. who, 2001)
D46.A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM D46.A became effective on October 1, 2022.
This is the American ICD-10-CM version of D46.A – other international versions of ICD-10 D46.A may differ.